EWA
BIOA

EverSource Wealth Advisors’s BioAge Labs BIOA Stock Holding History

EverSource Wealth Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.56K Sell
145
-24
-14% -$434 ﹤0.01% 3460
2026
Q1 		$2.95K Buy
169
+24
+17% +$462 ﹤0.01% 3497
2025
Q4 		$1.92K Buy
145
+35
+32% +$310 ﹤0.01% 3517
2025
Q3 		$647 Buy
110
+101
+1,122% +$473 ﹤0.01% 3872
2025
Q2 		$37 Sell
9
-27
-75% -$109 ﹤0.01% 4208
2025
Q1 		$135 Buy
+36
New +$166 ﹤0.01% 3772

Other funds holding BIOA

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

EverSource Wealth Advisors's BIOA Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its BioAge Labs (BIOA) stake by 14% in Q2 2026, selling an estimated $434 and leaving 145 shares worth $3.56K. The position accounts for ﹤0.01% of the portfolio, ranked #3460.

EverSource Wealth Advisors first reported a position in BIOA in Q1 2025 and has held it in 6 quarters since. 25 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • EverSource Wealth Advisors held 145 shares of BioAge Labs worth $3.56K as of Q2 2026.
  • EverSource Wealth Advisors sold 24 BioAge Labs shares in Q2 2026, an estimated $434.
  • BioAge Labs made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3460 holding.
  • EverSource Wealth Advisors first reported a position in BioAge Labs in Q1 2025 and has held it in 6 quarters since.
  • 25 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.